Robert Shumaker

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Vicky Makker, Matthew H. Taylor, Carol Aghajanian et al. · Journal of Clinical Oncology · 2020 · 512 citations · Full text

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

Vicky Makker, Drew Rasco, Nicholas J. Vogelzang et al. · The Lancet Oncology · 2019 · 470 citations · Full text

Advanced Endometrial Cancer, Interim Analysis, Medicine +6

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

Matthew H. Taylor, Chung‐Han Lee, Vicky Makker et al. · Journal of Clinical Oncology · 2020 · 446 citations · Full text

Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer

Anubha Gupta, Barbara Jarząb, Jaume Capdevila et al. · British Journal of Clinical Pharmacology · 2016 · 73 citations · Full text

Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults

Robert Shumaker, Jagadeesh Aluri, Jean Fan et al. · Clinical Drug Investigation · 2014 · 72 citations · Full text